Does CJC-1295 differ from Ipamorelin in its mechanism of action?
CJC-1295 acts as a synthetic analogue of growth hormone-releasing hormone that binds the GHRH receptor on anterior pituitary somatotrophs and activates adenylyl cyclase through Gs protein coupling. Ipamorelin acts as a selective growth hormone secretagogue that binds the ghrelin receptor through a Gq protein-coupled pathway that does not involve cyclic...









